PROTALIX BIOTHERAPEUTICS INC (PLX): Institutional Ownership
Hedge funds and institutional managers reporting a position in PLX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
7
13F filers
Aggregate Value
$3.0M
Across holders
Last Price
$2.30
2026-06-26
Sector
Health Care
GICS
Holder activity5 new0 added2 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 1.22M | $2.7M | 88.3% | 0.0% | Reduced | $-84K | Q1 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 76K | $195K | 6.5% | 0.0% | New | — | Q1 2025 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 26K | $56K | 1.9% | 0.0% | Reduced | $-4K | Q1 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 18K | $39K | 1.3% | 0.0% | New | — | Q1 2026 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 13K | $34K | 1.1% | 0.0% | New | — | Q1 2025 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 14K | $26K | 0.9% | 0.0% | New | — | Q4 2025 |
| AQR CAPITAL MANAGEMENT LLC CIK 0001167557 | Hedge Fund | 212 | $460 | 0.0% | 0.0% | New | — | Q1 2026 |
Reduced
Hedge Fund
$2.7M· 88.3% of total· 0.0% port· 1.22M sh· $-84K QoQ· Q1 2026
New
Hedge Fund
$195K· 6.5% of total· 0.0% port· 76K sh· — QoQ· Q1 2025
Reduced
Hedge Fund
$56K· 1.9% of total· 0.0% port· 26K sh· $-4K QoQ· Q1 2026
New
Hedge Fund
$39K· 1.3% of total· 0.0% port· 18K sh· — QoQ· Q1 2026
New
Hedge Fund
$34K· 1.1% of total· 0.0% port· 13K sh· — QoQ· Q1 2025
New
Hedge Fund
$26K· 0.9% of total· 0.0% port· 14K sh· — QoQ· Q4 2025
New
Hedge Fund
$460· 0.0% of total· 0.0% port· 212 sh· — QoQ· Q1 2026